Related references
Note: Only part of the references are listed.Genetic polymorphism of copper transporter protein 1 is related to platinum resistance in Chinese non-small cell lung carcinoma patients
Xiaojing Xu et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2012)
The CXXC motifs in the metal binding domains are required for ATP7B to mediate resistance to cisplatin
Roohangiz Safaei et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2012)
Prediction of copper transport protein 1 (CTR1) genotype on severe cisplatin induced toxicity in non-small cell lung cancer (NSCLC) patients
Xiaojing Xu et al.
LUNG CANCER (2012)
Mechanism of tumor resistance to cisplatin mediated by the copper transporter ATP7B
Oleg Y. Dmitriev
BIOCHEMISTRY AND CELL BIOLOGY (2011)
Six novel ATP7B mutations in Thai patients with Wilson disease
Benjaporn Panichareon et al.
EUROPEAN JOURNAL OF MEDICAL GENETICS (2011)
The status of platinum anticancer drugs in the clinic and in clinical trials
Nial J. Wheate et al.
DALTON TRANSACTIONS (2010)
The soluble metal-binding domain of the copper transporter ATP7B binds and detoxifies cisplatin
Nataliya V. Dolgova et al.
BIOCHEMICAL JOURNAL (2009)
Genetic Polymorphisms of Copper- and Platinum Drug-efflux Transporters ATP7A and ATP7B in Japanese Cancer Patients
Hiromi Fukushima-Uesaka et al.
DRUG METABOLISM AND PHARMACOKINETICS (2009)
Novel strategies for reversing platinum resistance
Mian M. K. Shahzad et al.
DRUG RESISTANCE UPDATES (2009)
Functional Interactions of Cu-ATPase ATP7B with Cisplatin and the Role of ATP7B in the Resistance of Cells to the Drug
Karoline Leonhardt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Characterization and analyses of multidrug resistance-associated protein 1 (MRP1/ABCC1) polymorphisms in Chinese population
Ji-Ye Yin et al.
PHARMACOGENETICS AND GENOMICS (2009)
Global analysis of genetic variation in SLCOIB1
Marja K. Pasanen et al.
PHARMACOGENOMICS (2008)
Transport of cisplatin by the copper efflux transporter ATP7B
Roohangiz Safaei et al.
MOLECULAR PHARMACOLOGY (2008)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
Trafficking of the copper-ATPases, ATP7A and ATP7B: Role in copper homeostasis
Sharon La Fontaine et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2007)
Function and regulation of human copper-transporting ATPases
Svetlana Lutsenko et al.
PHYSIOLOGICAL REVIEWS (2007)
The roles of copper transporters in cisplatin resistance
Macus Tien Kuo et al.
CANCER AND METASTASIS REVIEWS (2007)
Understanding cisplatin resistance using cellular models
Britta Stordal et al.
IUBMB LIFE (2007)
Role of copper transporters in the uptake and efflux of platinum containing drugs
R Safaei
CANCER LETTERS (2006)
Defective splicing, disease and therapy: searching for master checkpoints in exon definition
Emanuele Buratti et al.
NUCLEIC ACIDS RESEARCH (2006)
Splicing in action: assessing disease causing sequence changes
D Baralle et al.
JOURNAL OF MEDICAL GENETICS (2005)
Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) as a prognostic factor in human endometrial carcinoma
T Aida et al.
GYNECOLOGIC ONCOLOGY (2005)
Prognostic value of the Cu-transporting ATPase in ovarian carcinoma patients receiving cisplatin-based chemotherapy
K Nakayama et al.
CLINICAL CANCER RESEARCH (2004)
MALDI-TOF mass spectrometry - A versatile tool for high-performance DNA analysis
C Jurinke et al.
MOLECULAR BIOTECHNOLOGY (2004)
Modulation of the cellular pharmacology of cisplatin and its analogs by the copper exporters ATP7A and ATP7B
G Samimi et al.
MOLECULAR PHARMACOLOGY (2004)
Confocal microscopic analysis of the interaction between cisplatin and the copper transporter ATP7B in human ovarian carcinoma cells
K Katano et al.
CLINICAL CANCER RESEARCH (2004)
Identification and Characterization of the Rat M1 Muscarinic Receptor Promoter
Christoph P. R. Klett et al.
JOURNAL OF NEUROCHEMISTRY (2003)
The copper export pump ATP7B modulates the cellular pharmacology of carboplatin in ovarian carcinoma cells
K Katano et al.
MOLECULAR PHARMACOLOGY (2003)
Functional and structural consequences of cysteine substitutions in the NH2 proximal region of the human multidrug resistance protein 1 (MRP1/ABCC1)
EM Leslie et al.
BIOCHEMISTRY (2003)
Mutation analysis and the correlation between genotype and phenotype of Arg778Leu mutation in Chinese patients with Wilson disease
ZY Wu et al.
ARCHIVES OF NEUROLOGY (2001)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
